Carnegie acted as joint global co-ordinator and joint book-runner in the initial public offering of Pronova BioPharma ASA on the Oslo Stock Exchange. Pronova BioPharma ASA is a global leader in the research, development and manufacture of marine-originated omega-3 derived pharmaceuticals. October, 2007.
Healthcare
Initial public offering of Pronova BioPharma ASA (NO) — NOK 2.7 billion
October 2007